{
    "organizations": [],
    "uuid": "863913749bdfc52f230ef2058e93f221c96706ae",
    "author": "Thomas M. Burton",
    "url": "https://www.wsj.com/articles/fda-approves-migraine-medicine-1526609838",
    "ord_in_thread": 0,
    "title": "FDA Approves Migraine Medicine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The Food and Drug Administration on Thursday approved a new migraine drug from Amgen Inc. and Novartis AG that doctors say can change patientsâ€™ lives by lowering the number of migraine days suffered by patients each month.\nThe drug, called Aimovig, was shown in three clinical trials to do better than placebo in lowering the incidence of migraines.\nMigraines... ",
    "published": "2018-05-18T06:17:00.000+03:00",
    "crawled": "2018-05-19T04:04:38.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "food",
        "drug",
        "administration",
        "thursday",
        "approved",
        "new",
        "migraine",
        "drug",
        "amgen",
        "novartis",
        "ag",
        "doctor",
        "say",
        "change",
        "patient",
        "life",
        "lowering",
        "number",
        "migraine",
        "day",
        "suffered",
        "patient",
        "month",
        "drug",
        "called",
        "aimovig",
        "shown",
        "three",
        "clinical",
        "trial",
        "better",
        "placebo",
        "lowering",
        "incidence",
        "migraine",
        "migraine"
    ]
}